Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | AMGN | GILD | VRTX | REGN |
| Company | Emergent Biosolutions | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 6.93 | 335.15 | 83.26 | 474.36 | 1,145.99 |
| High | 6.97 | 338.97 | 83.99 | 474.93 | 1,149.42 |
| Low | 6.55 | 334.27 | 82.75 | 463.81 | 1,136.22 |
| Last | 6.55 | 337.38 | 83.94 | 464.92 | 1,145.03 |
| Change | -0.44 | +1.43 | +0.04 | -12.98 | -5.16 |
| % Change | -6.29% | +0.43% | +0.05% | -2.72% | -0.45% |
| Volume | 4,452,303 | 4,067,800 | 24,925,701 | 2,238,500 | 913,800 |
| 20-Day Average Volume | 2,220,850 | 1,855,480 | 7,644,680 | 1,043,340 | 450,565 |
| Previous Close | 6.99 | 335.95 | 83.90 | 477.90 | 1,150.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.86 | 330.23 | 80.47 | 479.12 | 1,163.38 |
| 20-Day Raw Stochastic | 0.00% | 91.90% | 89.42% | 10.69% | 32.45% |
| 20-Day Relative Strength | 41.32% | 58.76% | 71.95% | 43.24% | 51.59% |
| Weighted Alpha | -33.02 | +27.84 | +18.32 | +28.48 | +40.25 |
| Today's Opinion | 24% Buy | 100% Buy | 88% Buy | 24% Buy | 80% Buy |
| Previous Opinion | 24% Buy | 96% Buy | 88% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 96% Buy | 88% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.77% since 09/13/24 | +1.48% since 09/13/24 | +1.36% since 09/13/24 | -4.21% since 09/13/24 | -0.72% since 09/13/24 |
| Low | 6.55 on 09/20/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 463.81 on 09/20/24 | 1,134.59 on 09/17/24 |
| High | 7.93 on 09/16/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 1,165.85 on 09/19/24 |
| 1-Month | |||||
| %Chg | -32.05% since 08/20/24 | +2.69% since 08/20/24 | +12.29% since 08/20/24 | -4.61% since 08/20/24 | -3.96% since 08/20/24 |
| Low | 6.55 on 09/20/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 |
| High | 10.66 on 08/22/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +1.24% since 06/20/24 | +8.87% since 06/20/24 | +22.56% since 06/20/24 | -1.37% since 06/20/24 | +9.64% since 06/20/24 |
| Low | 5.25 on 08/07/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 |
| High | 15.10 on 07/30/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +160.96% since 03/20/24 | +23.56% since 03/20/24 | +13.46% since 03/20/24 | +12.81% since 03/20/24 | +18.42% since 03/20/24 |
| Low | 1.82 on 04/18/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 15.10 on 07/30/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 366,290 | 180,215,344 | 104,527,072 | 123,323,528 | 126,734,816 |
| Shares Outstanding, K | 52,402 | 536,435 | 1,245,853 | 258,053 | 110,186 |
| Annual Sales | 1,049,300,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -760,500,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 254,700,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 3,547,100,000 |
| Last Quarter Net Income | -283,100,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 1,432,300,000 |
| 60-Month Beta | 1.60 | 0.61 | 0.18 | 0.40 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/06/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/06/24 | 10/29/24 | 11/05/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 0.00 | 29.64 |